PANELISTS:
-
Graham Milner,
Executive Vice President, Global Innovation,
WD40
-
Dr. Robert J.
Wills, Vice President, Alliance Management,
Johnson & Johnson
-
Jo Mohr, Senior
Director, Open Innovation, GlaxoSmithKline
-
Plus executives
invited from Cisco, Kraft, and P&G
In this dynamic and
interactive session, Dr. Henry Chesbrough will lead
a discussion of how the Open Innovation concept has
driven measurable results in innovation and overall
business performance across industries. Panelists
include senior management from GlaxoSmithKline,
WD40, and other companies that have successfully
implemented various aspects of Open Innovation.
Dr. Chesbrough will
open the session by providing some of his thoughts
on how the Open Innovation concept has evolved since
his original book on the topic was published in
2003. He will then tee up a series of discussion
questions for the panelists to explore: why each of
their companies pursued an Open Innovation agenda,
what challenges they struggled to overcome, and what
real, quantifiable business performance improvements
they have seen as a result.
The session will
conclude with a 20-minute open Q&A period, allowing
the audience to directly pose questions to both Dr.
Chesbrough and the panelists.
